David Roman
Stock Analyst at Goldman Sachs
(1.88)
# 3,231
Out of 5,147 analysts
65
Total ratings
35.14%
Success rate
-4.88%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $363 → $326 | $246.61 | +32.19% | 2 | Feb 19, 2026 | |
| BAX Baxter International | Maintains: Neutral | $21 → $17 | $20.37 | -16.54% | 5 | Feb 17, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $108 → $95 | $86.47 | +9.86% | 5 | Feb 11, 2026 | |
| DOCS Doximity | Maintains: Neutral | $46 → $34 | $24.53 | +38.61% | 5 | Feb 9, 2026 | |
| MDLN Medline | Initiates: Buy | $49 | $47.51 | +3.14% | 1 | Jan 12, 2026 | |
| HQY HealthEquity | Downgrades: Sell | $89 | $76.49 | +16.36% | 4 | Jan 9, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $22 → $25 | $23.28 | +7.39% | 3 | Dec 15, 2025 | |
| COO The Cooper Companies | Maintains: Sell | $64 → $71 | $83.67 | -15.14% | 2 | Dec 8, 2025 | |
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $97.66 | +13.66% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Holdings | Maintains: Neutral | $180 → $202 | $133.75 | +51.03% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $33 | $12.63 | +161.28% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $16 | $18.30 | -12.57% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $103 | $120.40 | -14.45% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $13.56 | +47.49% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $14.57 | +30.40% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $12.28 | +136.16% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $98.44 | +5.65% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $5.26 | +90.11% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $84.27 | -2.69% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $116.35 | +32.36% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $25.30 | -5.14% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $74.20 | -4.31% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $70.60 | -22.10% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $387.46 | +10.20% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $76.85 | +17.11% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $503.51 | -0.70% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $176.48 | +55.26% | 1 | May 30, 2024 |
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $363 → $326
Current: $246.61
Upside: +32.19%
Baxter International
Feb 17, 2026
Maintains: Neutral
Price Target: $21 → $17
Current: $20.37
Upside: -16.54%
Edwards Lifesciences
Feb 11, 2026
Maintains: Buy
Price Target: $108 → $95
Current: $86.47
Upside: +9.86%
Doximity
Feb 9, 2026
Maintains: Neutral
Price Target: $46 → $34
Current: $24.53
Upside: +38.61%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $49
Current: $47.51
Upside: +3.14%
HealthEquity
Jan 9, 2026
Downgrades: Sell
Price Target: $89
Current: $76.49
Upside: +16.36%
Kestra Medical Technologies
Dec 15, 2025
Maintains: Neutral
Price Target: $22 → $25
Current: $23.28
Upside: +7.39%
The Cooper Companies
Dec 8, 2025
Maintains: Sell
Price Target: $64 → $71
Current: $83.67
Upside: -15.14%
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $97.66
Upside: +13.66%
iRhythm Holdings
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $133.75
Upside: +51.03%
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $12.63
Upside: +161.28%
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $18.30
Upside: -12.57%
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $120.40
Upside: -14.45%
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $13.56
Upside: +47.49%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $14.57
Upside: +30.40%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $12.28
Upside: +136.16%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $98.44
Upside: +5.65%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.26
Upside: +90.11%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $84.27
Upside: -2.69%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $116.35
Upside: +32.36%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $25.30
Upside: -5.14%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $74.20
Upside: -4.31%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $70.60
Upside: -22.10%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $387.46
Upside: +10.20%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $76.85
Upside: +17.11%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $503.51
Upside: -0.70%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $176.48
Upside: +55.26%